Steve Georas, MD
Enriched profileProfessor - Department of Medicine, Pulmonary Diseases and Critical Care (SMD) · University of Rochester Medical Center
Steve Georas is Professor - Department of Medicine, Pulmonary Diseases and Critical Care (SMD) at University of Rochester Medical Center. OpenAlex indexes 213 publications with 8,486 citations (h-index 48); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 21 Oct 2026
Overview
Updated 22 Oct 2026
Steve Georas, M.D., is Professor - Department of Medicine, Pulmonary Diseases and Critical Care (SMD) at University of Rochester Medical Center. The public record shows 213 publications with 8,486 citations (h-index 48), centered on Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Chronic Obstructive Pulmonary Disease (COPD) Research. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 9 companies, 8 NIH-funded awards (2006–2026).
- Most recent indexed publication: 2023 · American journal of respiratory and critical care medicine
- Top research focus: Asthma and respiratory diseases
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 105.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
Industry payments
Updated 22 Oct 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20243 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
76.2%Corticosteroid48.8%Trelegy Ellipta39%Symbicort15%Dulera14%Budesonide-Formoterol Fumarate13%Fluticasone Propionate9%Breo Ellipta6%Breyna5%Part D<11 patientsbeta2-Adrenergic Agonist10.5%Albuterol Sulfate Hfa100%Part D≥23 patients+ 4 more classes in this area
Dermatology
10.3%Interleukin-4 Receptor alpha Antagonist10.3%Dupixent Pen51%Dupixent Syringe49%Part D<11 patientsBlood & clotting
4.7%Human alpha-1 Proteinase Inhibitor2.3%Prolastin C100%Part D<11 patientsFactor Xa inhibitor2.3%Xarelto100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 22 Oct 2026
8 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
Publications
Updated 22 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- IgE Sensitization Drives the Atopic March.
American journal of respiratory and critical care medicine
Letter2023 - Diesel exhaust particle exposure reduces expression of the epithelial tight junction protein Tricellulin.
Particle and fibre toxicology
Article2020
Most-cited works
by citation count (OpenAlex)- 01Tight junction defects in patients with atopic dermatitisArticle747 citations2010
- 02Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in miceArticle580 citations2005
- 03
- 04
- 05
Network
Updated 22 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 22 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/steve-georas-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
Editorial & leadership roles
journal and society appointments- Walter & Carmina Mary Parkes Family Distinguished Professorship
Division of Pulmonary Diseases and Critical Care
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗ - Editorial board member
several journals (journals not named)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rochester.edu ↗ - Chair
study section, NHLBI
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rochester.edu ↗ - Chair
study section, NIAID
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rochester.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ann Falsey, MD
University of Rochester Medical Center
Supriya Mohile, MD
University of Rochester Medical Center
Paul Barr, MD
University of Rochester Medical Center
Christopher Ritchlin, MD
University of Rochester Medical Center
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital